HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost chemo for head and neck cancer
Disease control TerminatedThis early-phase trial tested whether adding the immunotherapy drug durvalumab to standard chemotherapy (docetaxel, cisplatin, and 5-FU) is safe for people with advanced head and neck cancer that hasn't spread. The study involved 14 adults under 75 with good performance status. T…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Cancer depression app study ends early after just one volunteer
Symptom relief TerminatedThis study aimed to see if a mental health app could help head and neck cancer survivors with depression. Participants would use the app for six weeks and fill out surveys. However, the study was stopped early and only enrolled one person, so no meaningful results were obtained.
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC